News
MedPage Today on MSN11h
Ozempic Shows Benefit in Type 1 Diabetes Patients With ObesityCHICAGO -- Semaglutide (Ozempic) reduced glucose levels and weight among patients with type 1 diabetes and obesity, a ...
Head-splitting migraines could be the next ailment in a seemingly endless list that a class of blockbuster weight-loss drugs ...
New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...
While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...
Semaglutide at a dose of 2.4 mg has established weight-loss and cardiovascular benefits, and cagrilintide at a dose of 2.4 mg ...
An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a prospective new ...
A new drug is helping families who've spent years padlocking fridges, chaining garbage cans, and hiding food as their ...
LSU’s Pennington Biomedical Research Center is working to prevent and treat childhood obesity in the state through its Greaux ...
Amgen’s monthly obesity candidate led to substantial weight loss but a high rate of side effects and discontinuations in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback